Nouveau Biosciences and CanceRx Announce Letter of Intent to Advance Next-Generation Oncology Therapies
Nouveau Biosciences and CanceRx Announce Letter of Intent to Advance Next-Generation Oncology Therapies
New York, NY and Tampa, FL – January 5, 2026 – Nouveau Biosciences, a biotechnology company pioneering nanomedicines and targeted drug delivery to improve cancer therapeutics, and CanceRx, a purpose-driven funding and development platform focused on advancing innovative oncology treatments through long-duration capital and strategic partnerships, today announced that the two organizations have entered into […]